Navigation Links
Human Genome Sciences Initiates First Clinical Trial of Lead IAP Inhibitor HGS1029 in Advanced Solid Tumors
Date:5/30/2008

ectives of the Phase 1 open-label, dose-escalation study are to evaluate the safety and tolerability of HGS1029 as monotherapy in patients with advanced solid tumors, and to select a recommended dose for Phase 2 studies. Secondary objectives include documenting possible anti-tumor activity and determining HGS1029's pharmacokinetic profile. HGS1029 will be administered as a 15-minute infusion once weekly for 3 consecutive weeks followed by a week off. Up to 40 patients will be treated in the study, with 15-20 patients treated in the dose-escalation phase.

About the HGS Oncology Portfolio

HGS is investing strategically to expand and advance its oncology portfolio around its leading expertise in the apoptosis pathway. HGS has initiated new chemotherapy combination trials of HGS-ETR1 (mapatumumab), added the new opportunity to develop and commercialize HGS1029 and other IAP inhibitors, and reacquired the rights to its TRAIL receptor antibodies. HGS-ETR1, the Company's antibody to TRAIL receptor 1, is the most advanced of any product in development that targets the TRAIL apoptosis pathway.

About Human Genome Sciences

The mission of HGS is to apply great science and great medicine to bring innovative drugs to patients with unmet medical needs.

The HGS clinical development pipeline includes novel drugs to treat hepatitis C, lupus, inhalation anthrax, cancer and other immune-mediated diseases. The Company's primary focus is rapid progress toward the commercialization of its two key lead drugs, Albuferon(R) for hepatitis C and LymphoStat-B(R) (belimumab) for lupus. Phase 3 clinical trials of both drugs are ongoing.

ABthrax(TM) (raxibacumab) is in late-stage development for the treatment of inhalation anthrax, and the Company is on track to begin the delivery in fall 2008 of 20,000 doses of ABthrax to the Strategic National Stockpile under a contract entered into with the U.S. Government in June 2006. Other HGS drugs in clinical devel
'/>"/>

SOURCE Human Genome Sciences, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Video: New Research Discovers Independent Brain Networks Control Human Walking
2. Lpath Demonstrates Strong Safety Profile of Lead Drug Candidate, Sphingomab(TM), in Non-Human Primates
3. Enrollment Begins on Human PK Study for Medidur(TM) FA
4. Human Genome Sciences Completes Enrollment of First Phase 3 Albuferon(R) Trial Ahead of Schedule
5. Study Confirms Limited Human-To-Human Spread of Avian-Flu Virus in Indonesia in 2006
6. Lpath Demonstrates Preclinical Efficacy of Lpathomab(TM) and Initiates Humanization Process
7. Peregrine Researchers Report Data Showing Bavituximabs Potential to Shrink Human Prostate Tumors in Model of Relapsed Disease
8. Dr. Roger Kenneth Hershline PhD MD, CEO of Global Humanceuticals, Inc. Donates New HIV Drug
9. Study Shows Plasma-Derived Human Thrombin Equivalent to Bovine Thrombin in Achieving Hemostasis in Surgery
10. Tengion Launches Second Phase 2 Clinical Trial of Regenerated Human Organ
11. Flexible Medical Systems Raises $1.2M Seed Investment for Initial Human Trials
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/19/2014)... 19, 2014  As power morcellator lawsuits continue ... Liebhard LLP notes that women in need of ... number of options that do not involve the ... to a report published by The Wall Street ... include a mini-laparotomy and vaginal hysterectomy. Non-surgical options ...
(Date:8/19/2014)... Research and Markets has announced the ... by Technology, by Application & by Region- Global Trends & ... The demand for membranes is estimated to increase at ... $29.31 billion Membrane technology was first commercialized in ... filtration and kidney dialysis. In modern times, membranes find extensive ...
(Date:8/19/2014)... Va. , Aug. 19, 2014 Avizia, ... announced that it has closed an equity financing round ... and Middleland Capital. The new funding will be used ... With this financing round, Avizia welcomes Edward Kennedy ... board of directors. He joins Leonard Kurtzman , ...
Breaking Medicine Technology:As Morcellator Lawsuits Mount, Bernstein Liebhard LLP Notes Report Detailing Alternatives to Uterine Morcellation 2As Morcellator Lawsuits Mount, Bernstein Liebhard LLP Notes Report Detailing Alternatives to Uterine Morcellation 3Global Membranes (MF, RO, UF, Gas Separation, Dialysis, NF) Market - Forecasts to 2019 2Avizia Closes Funding Round 2
... June 30 If you have been eating Garlic to keep ... there is absolutely no scientific evidence that eating garlic actually keeps ... keeps them away. , , Spraying garlic extract on ... a product from Garlic Research Labs, Inc. is being used successfully ...
... Accumetrics, Inc. announces that it has reached the halfway mark ... GRAVITAS ( G auging R esponsiveness with A ... A nd S afety). The trial is ... actionable information for patients who are poor responders to clopidogrel ...
Cached Medicine Technology:Keep Mosquitoes and More Out of Your Yard with Garlic From Garlic Research Labs, Inc. 2Accumetrics, Inc. Announces GRAVITAS Trial 50 Percent Enrolled 2
(Date:8/20/2014)... August 20, 2014 The report ... Cars - A Global Analysis: by Geography - ... MarketsandMarkets, classifies and defines automotive airbag and seatbelt ... report highlights potential growth opportunities in the coming ... – market drivers, restrains, growth indicators, challenges, legislation ...
(Date:8/20/2014)... 2014 In a recent article published ... College London (UCL) study showed that dental experts from ... brushing teeth was the most effective. Analysis of 66 ... techniques were frequently recommended, but none were favored by ... Dentistry, experienced cosmetic dentist Dr. Patrick J. ...
(Date:8/20/2014)... August 20, 2014 Hope For The ... Hope® Celebration to be hosted in Washington, DC on ... Club. This signature event honors the courage of our ... the fallen. Proceeds from the Got Heart, Give Hope® ... nonprofit dedicated to restoring a sense of self, restoring ...
(Date:8/20/2014)... (PRWEB) August 20, 2014 No matter how ... count on a steady set of friends to be always ... it comes to the concept of making new friends ... various responsibilities ranging from taking care of one’s family to ... with talking to a new person just is not the ...
(Date:8/20/2014)... Ticketability.com has Theresa Caputo tickets ... The well-known medium has been thrilling many with her ... 19 cities, with tickets becoming available August 15. , ... are Albany, Baltimore, Trenton, Erie, Buffalo, Philadelphia, Charlotte, Houston, ... San Diego. The medium’s fans can obtain Theresa Caputo ...
Breaking Medicine News(10 mins):Health News:Automotive Airbag Market Worth $23.6 Billion and Automotive Seat Belt Market Worth $9.0 Billion by 2019 – New Report by MarketsandMarkets 2Health News:Automotive Airbag Market Worth $23.6 Billion and Automotive Seat Belt Market Worth $9.0 Billion by 2019 – New Report by MarketsandMarkets 3Health News:Automotive Airbag Market Worth $23.6 Billion and Automotive Seat Belt Market Worth $9.0 Billion by 2019 – New Report by MarketsandMarkets 4Health News:Ending Confusion About the Best Way to Brush Teeth 2Health News:Ending Confusion About the Best Way to Brush Teeth 3Health News:Hope For The Warriors Announces Got Heart, Give Hope Celebration in Washington, DC 2Health News:‘How to Make Friends as an Adult by Just Being Yourself: Becoming a “People Person” In Three Steps or Less’ Gives Tips for Making Friends During Adulthood - Vinamy 2Health News:Theresa Caputo Tour Tickets for Sale at Ticketability.com Cause a Buying Frenzy Among Customers Over Their Offering of Deeply Discounted Seats 2
... a new study, people with Down syndrome live twice as long ... a lower than average risk of developing many forms of cancer. ... week's Lancet was based on data collected from death certificates between ... average age at death for the 10,800 reported to have Down ...
... memory loss is often an indicator of Alzheimer's disease and is ... of controversy over the implications of mild cognitive decline the loss ... solving and planning.Some people think it is a normal part of ... while there is also the view that it's a disease in ...
... side of the brain helps people recognise themselves in ... Beth Israel Deaconess Medical Center in Boston report their ... study joins a growing body of evidence that demonstrates ... Studies of self-awareness may provide unique insights into consciousness ...
... to drink more to feel drunk than non-smoking drinkers – ... livers and hearts, a new study suggests.// ,The study ... are considered a good model for humans.Since alcohol abusers generally ... to get an expected level of intoxication, say the researchers ...
... a potential new treatment for people with severe cases of ... involves removing stem cells// from the patients’ blood, killing the ... then returning the healthy cells back to the body. The ... healthy immune system cells and the disease process can be ...
... People who take the cholesterol-lowering drugs called statins may ... 80%. Statins have been proved to offer// powerful protection ... The findings provide the strongest evidence to date that ... disease. ,An earlier, smaller study had suggested ...
Cached Medicine News:Health News:Down syndrome life anticipation doubles 2Health News:Right side of the brain helps in awareness 2
Speculum can be used for any type of eye surgery. Arms of speculum lie flat due to joint between blade and arms. Features quick locking mechanism....
Adult model. Spring-controlled spread of blades with locking mechanism. Dull finish. Blades: 14 mm....
Solid 14 mm blades, suture posts, and canthus bar. Dull finish....
... the E3671 twisted snare wires. The wire is ... the loop can be stopped at any point. ... loop can be slipped down the nerve before ... Comes with one package of E3671 twisted snare ...
Medicine Products: